American Century Companies’s Aegerion Pharmaceuticals AEGR Stock Holding History

American Century Companies’s Portfolio AEGR Stock Details AEGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-54,008	Closed	-$545K	–	1425
2015 Q4	$545K	Buy	+54,008	New	+$650K	﹤0.01%	1189
2014 Q4	–	Sell	-25,346	Closed	-$846K	–	1521
2014 Q3	$846K	Buy	25,346 +197	+0.8%	+$6.11K	﹤0.01%	1213
2014 Q2	$807K	Sell	25,149 -446	-2%	-$16.6K	﹤0.01%	1257
2014 Q1	$1.18M	Sell	25,595 -502,310	-95%	-$29.5M	﹤0.01%	1191
2013 Q4	$37.5M	Buy	527,905 +22,710	+4%	+$1.74M	0.04%	411
2013 Q3	$43.3M	Buy	505,195 +479,050	+1,832%	+$40.6M	0.05%	365
2013 Q2	$1.66M	Buy	+26,145	New	+$1.39M	﹤0.01%	1125

Other funds holding AEGR

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

American Century Companies's AEGR Position: Q1 2016 in Review

American Century Companies sold out of Aegerion Pharmaceuticals (AEGR) in Q1 2016, closing a stake of 54,008 shares — an estimated $545K sold.

American Century Companies first reported a position in AEGR in Q2 2013 and held it in 7 quarters. The position peaked at $43.3M in Q3 2013. 101 funds tracked by Wall St. Rank hold AEGR as of Q1 2016.

American Century Companies reported no remaining Aegerion Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
American Century Companies sold 54,008 Aegerion Pharmaceuticals shares in Q1 2016, an estimated $545K.
American Century Companies first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 7 quarters.
American Century Companies's Aegerion Pharmaceuticals position peaked at $43.3M in Q3 2013.
101 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q1 2016.

Based on American Century Companies's 13F filing for Q1 2016, filed 2 May 2016.